ReviewCurrent nutrition reports2025
Flaxseed in Diabetes Management: Nutritional and Therapeutic Insights.
Review in Current nutrition reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewDiabetes mellitus is a prevalent metabolic disorder contributing to significant global health challenges. As interest in alternative therapies grows, flaxseed rich in omega-3 fatty acids, lignans, and fiber has garnered attention for its potential role in diabetes management. RECENT
findingsThe reviewed literature suggested that various components present in flaxseeds are known to combat impaired carbohydrate metabolism including the other associated diabetic abnormalities like oxidative stress markers, inflammation, and hypercholesterolemia. Taken together, this review has highlighted the essential constituents of flaxseed and their potential mechanisms in reducing fasting blood glucose levels, alleviating oxidative stress, balancing lipid profiles, and regulating inflammatory markers in individuals with diabetes. Flaxseed, whether consumed whole or in various processed forms, may serve as a complementary therapy alongside conventional antidiabetic medications.
Indexed as
Identifiers
40991096What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.